• Home
  • About Cellphire
  • Our Technology
    • Overview
    • Product Development
    • Cellphire Publications
  • Clinical Trials
  • Partnering Opportunities
  • News
  • Careers
  • Contact Us
  • 9430 Key West Avenue Rockville, MD 20850 I (240) 268.1141
  1. Cellphire Investors Receive 50% Maryland Biotechnology Investment Incentive Tax Credit

    (September 2016) Cellphire, Inc. announced today that all investors who participated in the $1.3M Cellphire funding round that closed in August have received their Final Tax Credit Certificates from the Maryland Department of Commerce awarding them a 50 percent refundable tax credit for their investments in Cellphire. They are now able to claim the tax […]

    Category: Uncategorized Comments Off on Cellphire Investors Receive 50% Maryland Biotechnology Investment Incentive Tax Credit


  • Recent Posts

    • Cellphire President G. Michael Fitzpatrick Awarded Armed Services Program Lifetime Achievement Award
    • Cellphire Subsidiary, BodeVet, Inc., Awarded $1.7 Million U.S. Army Contract
    • Cellphire Announces Orphan Drug Designation of Thrombosomes® for Treatment of Acute Radiation Syndrome
    • Cellphire Announces Exercise by BARDA of Option 3 of Contract to Develop Platelet-Based Hemostatic
    • Cellphire Begins Phase 2 Trial of Thrombosomes® in Bleeding Thrombocytopenic Patients
  • Categories

    • No categories
  • Archives

    • September 2020
    • June 2020
    • May 2020
    • April 2020
    • March 2020
    • January 2020
    • November 2019
    • July 2019
    • May 2019
    • January 2019
    • October 2018
    • November 2017
    • August 2017
    • July 2017
    • June 2017
    • April 2017
    • March 2017
    • January 2017
    • November 2016
    • September 2016
    • August 2016
    • March 2016
    • April 2015
    • June 2014
    • February 2014
  • Home
  • //
  • About Cellphire
  • //
  • Our Technology
  • //
  • Partnering Opportunities
  • //
  • News
  • //
  • Careers
  • //
  • Contact Us

Copyright © 2021